EMA begins review of Pfizer COVID jab for young teens as US set to OK it
EMA begins review of Pfizer COVID jab for young teens as US set to OK it

The US is expected to back the use of the Pfizer/BioNTech vaccine for people aged 12 to 15 within a week.

Europe's watchdog launched its review on Monday with a decision expected in June.